Shares of Health Care sector company Globus Medical moved 0.6% today, and are now trading at a price of $54.92. The mid-cap stock's daily volume was 89,872 compared to its average volume of 1,309,139. The S&P 500 index returned a 0.0% performance.
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company is based in Audubon and has 2,600 full time employees. Its market capitalization is $7,567,590,912.
12 analysts are following Globus Medical and have set target prices ranging from $53.0 to $83.0 per share. On average, they have given the company a rating of hold. At today's prices, GMED is trading -15.18% away from its average analyst target price of $64.75 per share.
Over the last year, GMED shares have gone down by -26.3%, which represents a difference of -47.4% when compared to the S&P 500. The stock's 52 week high is $80.04 per share and its 52 week low is $43.39. With average free cash flows of $135.2 Million that have been growing at an average rate of 3.0% over the last 6 years, Globus Medical declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 202,800 | 73,733 | 129,067 | 23.6 |
| 2022 | 178,468 | 74,047 | 104,421 | -52.4 |
| 2021 | 276,274 | 56,898 | 219,376 | 62.34 |
| 2020 | 198,793 | 63,658 | 135,135 | 33.5 |
| 2019 | 171,975 | 70,750 | 101,225 | -16.99 |
| 2018 | 181,643 | 59,697 | 121,946 |
